Innospec Inc. (NASDAQ:IOSP) Receives Average Rating of “Moderate Buy” from Analysts

Innospec Inc. (NASDAQ:IOSPGet Free Report) has been assigned a consensus rating of “Moderate Buy” from the three brokerages that are covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and one has assigned a strong buy rating to the company.

A number of equities analysts have commented on the stock. Zacks Research raised shares of Innospec from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. Wall Street Zen upgraded Innospec from a “hold” rating to a “buy” rating in a research report on Saturday. Finally, Weiss Ratings upgraded Innospec from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday.

Check Out Our Latest Report on IOSP

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. Nuveen LLC purchased a new position in shares of Innospec during the 1st quarter worth about $42,966,000. Financial Harvest LLC purchased a new position in shares of Innospec during the first quarter valued at approximately $41,107,000. Brown Advisory Inc. purchased a new position in shares of Innospec during the first quarter valued at approximately $31,212,000. Victory Capital Management Inc. boosted its position in shares of Innospec by 20.0% during the first quarter. Victory Capital Management Inc. now owns 1,106,482 shares of the specialty chemicals company’s stock valued at $104,839,000 after buying an additional 184,262 shares during the period. Finally, Millennium Management LLC boosted its holdings in Innospec by 8,176.5% during the 1st quarter. Millennium Management LLC now owns 170,414 shares of the specialty chemicals company’s stock valued at $16,147,000 after acquiring an additional 168,355 shares during the period. 96.64% of the stock is owned by hedge funds and other institutional investors.

Innospec Stock Performance

IOSP stock opened at $73.92 on Wednesday. The firm has a fifty day moving average price of $81.86 and a 200 day moving average price of $85.39. Innospec has a fifty-two week low of $73.72 and a fifty-two week high of $128.35. The firm has a market cap of $1.84 billion, a PE ratio of 94.77 and a beta of 1.04.

Innospec (NASDAQ:IOSPGet Free Report) last posted its earnings results on Tuesday, August 5th. The specialty chemicals company reported $1.26 earnings per share for the quarter, beating analysts’ consensus estimates of $1.17 by $0.09. Innospec had a net margin of 1.08% and a return on equity of 10.89%. The firm had revenue of $439.70 million during the quarter, compared to analyst estimates of $440.70 million. During the same period last year, the firm posted $1.39 earnings per share. Innospec’s revenue for the quarter was up 1.1% compared to the same quarter last year. On average, equities analysts predict that Innospec will post 6.18 EPS for the current year.

Innospec Company Profile

(Get Free Report)

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.

See Also

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.